Chronic pain is a massive problem, affecting 1.7 billion people and often lacking objective ways to measure or treat it. Researchers found a solution by identifying two brain biomarkers that predict pain sensitivity with 88% accuracy. By measuring brain excitability and frequency, doctors can now identify who is at risk of long-term suffering. The benefit is personalized care that stops acute pain from becoming chronic, offering patients a better quality of life.
